Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00138151
What this trial is testing

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
University of Medicine and Dentistry of New Jersey 33
Large-scale testing (Phase 3)Study completedNCT00459667
What this trial is testing

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 1,420
Large-scale testing (Phase 3)Study completedNCT01448044
What this trial is testing

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 152
Testing effectiveness (Phase 2)Study completedNCT00047658
What this trial is testing

The Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
InterMune 32
Post-approval studies (Phase 4)Study completedNCT02247440
What this trial is testing

HCV-HIV Co-infected Patient Cohort in Thailand

Who this might be right for
Hepatitis C InfectionHIV
Institut de Recherche pour le Developpement 18
Testing effectiveness (Phase 2)Study completedNCT00002733
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Hoag Memorial Hospital Presbyterian 30
Not applicableStudy completedNCT00247884
What this trial is testing

Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV

Who this might be right for
Hepatitis C Virus Infection
University of British Columbia 50
Testing effectiveness (Phase 2)Study completedNCT04667104
What this trial is testing

JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 48
Not applicableStudy completedNCT01184833
What this trial is testing

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 852
Not applicableEnded earlyNCT00209755
What this trial is testing

Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Hopital A Michallon 40
Testing effectiveness (Phase 2)Study completedNCT01146535
What this trial is testing

Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

Who this might be right for
Influenza A Virus Infection
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00030849
What this trial is testing

Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00563212
What this trial is testing

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
NYU Langone Health 12
Not applicableUnknownNCT01083251
What this trial is testing

The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B Virus
Ziv Hospital 120
Early research (Phase 1)Study completedNCT01119781
What this trial is testing

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

Who this might be right for
HealthyRenal Insufficiency
Biogen 35
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Not applicableStudy completedNCT00724230
What this trial is testing

Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 505
Large-scale testing (Phase 3)Study completedNCT00002556
What this trial is testing

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 312
Large-scale testing (Phase 3)Study completedNCT00248339
What this trial is testing

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Virginia Commonwealth University 150
Testing effectiveness (Phase 2)Looking for participantsNCT05440422
What this trial is testing

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Who this might be right for
Systemic Lupus ErythematosusCardiovascular DiseasePremature Atherosclerosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 45
Next Page